New antibiotic combo tested in teens: safety first
NCT ID NCT07092813
First seen Jan 04, 2026 · Last updated May 23, 2026 · Updated 14 times
Summary
This early-stage study is testing an investigational antibiotic combination (sulopenem etzadroxil plus probenecid) in 12 adolescents who are already receiving standard antibiotics for a bacterial infection. The main goal is to see if the drug is safe and tolerable in this age group, and to measure how the body absorbs, processes, and eliminates it. Participants will take a single dose and provide blood and urine samples over 12 hours.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOKINETICS AFTER ORAL INTAKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical facility
RECRUITINGLittle Rock, Arkansas, 72205, United States
Conditions
Explore the condition pages connected to this study.